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Mutations in filamin 1 Prevent Migration
of Cerebral Cortical Neurons
in Human Periventricular Heterotopia
of directed cellular migration. Neurons of the cerebral
cortex are not generated in situ but instead arise in a
specialized germinal zone deep in the brain, called the
ventricular zone, and must migrate as many as thou-
sands of cell body lengths into the region of the future
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Long-range, directed migration is particularly dra- ents primarily in females (Huttenlocher et al., 1994; EksË i-
matic in the cerebral cortex, where postmitotic neu- ogÆ lu et al., 1996). Therefore, the neurons that fail to
rons generated deep in the brain migrate to form layers migrate are likely to represent those cells that, due to
with distinct form and function. In the X-linked domi- X inactivation, express genes from the X chromosome
nant human disorder periventricular heterotopia (PH),
that carries the mutated copy of the PH gene. Remark-
many neurons fail to migrate and persist as nodules
ably, most females with PH show normal intelligencelining the ventricular surface. Females with PH present
but suffer from seizures and pleiomorphic extra-CNSwith epilepsy and other signs, including patent ductus
signs, especially relating to the vascular system (Hutten-arteriosus and coagulopathy, while hemizygous males
locher et al., 1994; EksË iogÆ lu et al., 1996). Most malesdie embryonically. We have identified the PH gene as
with PH gene mutations die during early embryogenesisfilamin 1 (FLN1), which encodes an actin-cross-linking
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nonneural tissues.locomotion of many cell types. FLN1 shows previously
Here, we show that PH reflects spontaneous, de novo,unrecognized, high-level expression in the developing
intragenic mutations in a single gene, filamin 1 (FLN1,cortex, is required for neuronal migration to the cortex,
also known as nonmuscle filamin, actin binding proteinand is essential for embryogenesis.
280, and ABP-280), and detail the CNS and extra-CNS
phenotypes of FLN1 mutations. FLN1 is a 280 kDa actin-Introduction
cross-linking phosphoprotein originally isolated from
motile blood cells and subsequently shown to be ex-The migration of neurons into the mammalian cerebral
pressed in many nonmuscle cells (Hartwig et al., 1980;cortex provides an excellent system for genetic study
Hartwig and Shevlin, 1986; Gorlin et al., 1990; Hartwig,
1992). FLN1 has been shown to be essential for migra-9 To whom correspondence should be addressed (e-mail: cwalsh@
bidmc.harvard.edu). tion in melanocytes and other cultured cells by in vitro
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never suspected. Here, we show that FLN1 is particularly
enriched in the brain during the period of most active
neuronal migration and then is downregulated in the
adult. Our data also suggest that FLN1 is essential for
normal embryonic development and may have essential
roles in developing blood vessels.
Results
Genetic and Physical Mapping of the PH Locus
We previously mapped the PH gene to the distal long
arm of the X chromosome (Xq28) with a candidate inter-
val of z6.5 Mbp from the marker DXS1113 to the subtel-
omeric, pseudoautosomal region of Xq28 (EksË iogÆ lu et
al., 1996) (Figure 2a). We refined this interval further
by reexamining at higher marker resolution our most
informative recombination event in a PH patient who
carried unaffected alleles for DXS1113 and centromeric
markers (patient III-2; Figure 1d in EksË iogÆ lu et al., 1996).
The informative pedigree was reanalyzed with the ad-
ditional published markers DXS1176 (GDB number
207343), DXS15 (GDB number 207346), and BGN (Just
et al., 1994) (Figure 2a). The critical affected individual
was recombinant for DXS15 but nonrecombinant for
BGN, z100 kbp distal to DXS15, and was also nonre-
combinant for all markers distal to BGN. These data
place the crossover event between DXS15 and BGN and
reduce the PH candidate interval to z1 cM (z2.5 Mbp)
between DXS15 and the pseudoautosomal region of
Xq28 (Figure 2a).
Subsequent analysis of a large duplication of Xq28 in
a male PH patient (Fink et al., 1997) with a severe, albeit
nonlethal, phenotype allowed the candidate interval to
be refined even further, on the hypothesis that this pa-
tient was affected due to duplication or disruption of
the PH gene. Quantitative Southern blotting (Figures 2b
and 2d), confirmed by FISH analysis (data not shown),Figure 1. Anatomical Phenotype of PH with Different FLN1 Muta-
tions Shows Similar Features defined the approximate centromeric border of the du-
plication. Identification of novel restriction fragments(a) MRI of normal human cortex, performed using T1-weighting and
formatted in the axial plane, showing normal ventricles with normally (Figure 2c), followed by linker-mediated PCR amplifica-
smooth ventricular epithelium. tion and DNA sequencing of the junction fragments
(b) MRI formatted in a similar plane and with similar technique, (J. W. F., E. D. L., W. B. D., C. A. W., and B. A. H,
showing the affected mother from pedigree 2 (Figure 3b).
unpublished data), defined the exact centromeric bound-(c) Axial MRI of affected female III-10 from pedigree 1 (Figure 3a).
ary of the duplicated segment of Xq28 as base 3377 ofMRI was formatted in the same plane, but with greater T2-weighted
3395 of intron 1 of the isocitrate dehydrogenase genetechnique, so that the gray matter now appears brighter white than
gray matter in (a) and (b). (IDH), z600 kbp distal to DXS15. However, none of the
(d±f) Axial MRI of sporadic patients from Figure 3e, Figure 3c, and genes identified at the breakpoints or insertion site of
Figure 3d, respectively, taken with technique and formatting similar the duplication harbored independent mutations in other
to (a) and (b). MRI of each of the five PH brains (all showing distinct
PH patients. Therefore, we concluded that the duplica-FLN1 mutations) show somewhat enlarged ventricles and near-con-
tion itself was responsible for PH in this patient. Thistinuous bilateral lining of ectopic gray matter nodules (arrows). For
patient redefined the likely PH gene region as betweencomparison, ventricular surfaces free from heterotopias are marked
with asterisks. IDH and the pseudoautosomal region, a distance of
z1.9 Mbp.
genetic and cellular studies (Stendahl et al., 1980; Cun-
ningham et al., 1992). FLN1 appears to directly link mem- Candidate Gene Analysis of PH
Having narrowed the PH candidate interval, we movedbrane receptors to the actin cytoskeleton, to regulate
the formation of actin stress fibers and adhesive con- next to candidate gene analysis. Because distal Xq28 is
extremely gene dense, with a number of human diseasestacts, and to bind several other crucial regulators of the
cytoskeleton such as SEK-1 and Trio (Matsudaira, 1994; mapping to this area, a substantial fraction of the 1.9
Mbp PH candidate region has been completely se-Marti et al., 1997; Bellanger et al., 1998). However, the
in vivo effects of loss of FLN1 function have never been quenced (Figure 2). The sequenced area distal to IDH
covers 643 kbp (GenBank accession numbers U52111,known, and a role for FLN1 in migrating neurons was
Filamin 1 and Neuronal Migration
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Figure 2. Genetic and Physical Mapping of PH Locus
(a) The 6.5 Mbp ªprevious candidate intervalº was defined by a recombination event between the DXS1113 marker and the PH locus
(EksË iogÆ lu et al., 1996). This informative recombination event was further characterized with additional markers including DXS15 and BGN. The
recombination event occurred between these two markers, and the candidate interval was thus refined to distal of DXS15 (ªnew mapped
intervalº). The identification of the proximal boundary of a chromosomal duplication in an additional PH patient allowed the PH candidate
interval to be further narrowed to include only those genes telomeric to the isocitrate dehydrogenase (IDH) gene. All characterized genes in
the candidate region are shown. The distal boundary of the candidate interval is the pseudoautosomal region (PAR). The 643 kbp of Xq28
that is fully sequenced is depicted in black.
(b±d) The definition of the proximal boundary of the Xq28 duplication using Southern blot analysis. All three panels show sequential Southern
hybridization with three different probes to the same filter, containing DNA isolated from the mother of a male with periventricular heterotopia,
both of whom carry a duplication of distal Xq28 (labeled ªdupº) (Fink et al., 1997). Hybridization to a PCR-generated probe from the region
of the PLEXR gene (Figure 2b), not duplicated, shows equal in a normal female (lane 1), the patient with the duplication (lane 2), and a normal
male. Two bands are seen in the normal state since the probe spans a restriction site. Hybridization to a probe generated from the IDH gene
(at the centromeric border of the duplication) shows normal bands in lanes 1 and 3 and a normal band (from the normal X chromosome in
this female carrying the duplication) and an abnormal junction fragment in lane 2 (Figure 2c, marked by an asterisk). Similar abnormal fragments
were seen with five different restriction enzymes and confirmed by PCR amplification and direct sequencing of the junction site. Hybridization
to a third, more distal, duplicated probe from the region of G6PD (Figure 2d) shows increased hybridization in the female carrying the
duplication. These hybridization findings were consistent and reproducible with multiple probes and confirmed by dosage analysis with FISH.
U52112, AF030876, Z47046, Z47066, Z68193, Z46936, (Patrosso et al., 1994). The gene is adjacent to the emerin
gene (which causes Emery-Dreyfuss muscular dystro-Z49258, and L44140) and contains 23 characterized
genes. The z1.2 Mbp unsequenced area telomeric to phy, EDMD), and the two genes are flanked by inverted
repeats, causing the genomic segment containing thesethe 643 kbp sequenced block has a lower gene density
but still harbors at least a dozen additional genes, two genes to be present in two orientations in the popu-
lation at large (Small et al., 1997). All large scale re-though most are incompletely characterized (Rogner et
al., 1996). More than half of the genes in the PH candi- arrangements of emerin associated with EDMD had no-
tably failed to include FLN1, suggesting that loss ofdate interval are expressed at some detectable level in
brain and thus were formally candidates for the PH gene. FLN1 function might be embryonically lethal (Small and
Warren, 1998). FLN1 was tested as a candidate geneCandidate genes were tested in PH patients by Southern
blotting to search for gross rearrangements, and/or per- for PH in 25 females (representing either sporadic cases
or representatives of distinct pedigrees) by PCR ampli-forming single-stranded conformational polymorphism
analysis (SSCP) to search for intragenic point mutations. fying genomic DNA from single exons and analyzing the
products by SSCP. Screening of exons 2±5, represent-A partial list of candidate genes tested includes XAP3
(Sedlacek et al., 1993), XAP4 (also known as Rab3a ing the first four coding exons (11% of the full ORF)
and encoding the actin-binding domain (Patrosso et al.,GTPase dissociation inhibitor, and subsequently found
to be mutated in nonsyndromic X-linked mental retarda- 1994), alone showed several point mutations, which are
described here. In SSCP analysis, aberrantly migratingtion) (D'Adamo et al., 1998), XAP5, XAP6 (Maestrini et
al., 1996), XAP7, MPP1, CDM, PMCA3, IDH, TRAP, and bands were observed in five unrelated patients (Figure
3) for exons 2±5. Normal and aberrant bands were elutedPLEXR. While several benign sequence polymorphisms
or restriction fragment length polymorphisms were dis- from the gels, reamplified, and sequenced alongside
normal controls as well as the original heterozygouscovered in some of these genes, none of them harbored
any mutations in PH patients. In contrast, FLN1 immedi- PCR products used for the SSCP analysis. When appro-
priate, all available family members were amplified andately showed multiple deleterious mutations by SSCP
analysis and DNA sequencing. analyzed similarly (Figures 3a and 3b). Each aberrant
band was found to represent a loss-of-function mutation
upon DNA sequence analysis.FLN1 Mutations in PH
In the largest reported PH pedigree (Huttenlocher etFLN1 consists of 48 exons covering 26 kbp of genomic
sequence and has a 7.9 kb open reading frame (ORF) al., 1994), we found a C to T substitution in exon 3 (Figure
Neuron
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females in the pedigree. Moreover, a distant branch of
this same family was available for haplotype analysis
using flanking markers and demonstrates the de novo
origin of the mutation (Figure 3a). First cousins (III-2,
III-3, and III-4) of the oldest known affected female (III-
10) share the ªaffectedº haplotype (the chromosome
that carries DXS15 allele 2 and F8C allele 5) but do
not harbor the FLN1 mutation and are phenotypically
normal. In contrast, all descendants of III-10 who carry
the affected haplotype also harbor the nonsense FLN1
mutation and present with PH.
In a second pedigree, we identified a T to C substitu-
tion at the second base of intron 4 (Figure 3b) in the
splice donor sequence (AGgtaca to AGgcaca). A ªtº at
position 12 of the intron is conserved among 100% of
vertebrate splice junctions studied (Shapiro and Sena-
pathy, 1987). The mutation is predicted to cause either
exon skipping or a read-through of intron 4, which would
introduce a stop codon after the translation of 30 addi-
tional amino acids. The mutation is present both in a
mother and daughter with PH but not in the unaffected
maternal grandmother. Therefore, this mutation also
most likely arose de novo in this pedigree in the germline
of either the maternal grandmother or grandfather, both
of whom were clinically unaffected.
Three other mutations were identified in sporadic PH
patients. In the first (Figure 3c), the consensus splice
acceptor at the end of intron 3 (3 bases from exon 4) is
mutated by a C to G substitution (ccacagG to ccagagG).
The ªcº at position 23 is conserved among .70% of
vertebrate splice junctions, and a ªgº at this position is
only seen in 1% (Shapiro and Senapathy, 1987). The
mother of this patient is phenotypically normal and does
Figure 3. FLN1 Mutations in PH Patients not harbor the mutant allele. Thus, it is likely that this
Affected patients are shaded, and individuals genotyped and ana- mutation arose de novo in the germline of the patient's
lyzed by SSCP are large and bold. SSCP results are presented mother or father. The second sporadic mutation (Figure
directly below screened individuals. 3d) is a G to A substitution at the first base of intron 2
(a) The largest reported PH pedigree (Huttenlocher et al., 1994).
in the conserved splice donor (TCGgt to TCGat). TheAffected females show two additional SSCP bands, indicating heter-
ªgº at position 11 of the intron is conserved in 100%ozygosity for a CAG (Gln) to a TAG (stop) nonsense mutation (shown
of splice donor sequences of vertebrate genes (Shapiroin chromatogram on left), which truncates the FLN1 protein near
the N terminus (amino acid 182 of 2648). The genotype of analyzed and Senapathy, 1987). These two splicing mutations
individuals for two markers flanking the FLN1 locus, DXS15 and are again predicted to either cause exon skipping or
F8C, are shown. All affected individuals shared the same haplotype truncation of the FLN1 protein due to a read-through of
at DXS15, F8C, as well as for four other Xq28 markers between
the respective introns with the introduction of a stopthem. The mutation arose de novo on the ª2,5º chromosome in the
codon. The final sporadic mutation is a 5 base deletiongermline of either individual I-1, I-2, or II-5, as the mutation is absent
within the coding region of exon 2 (Figure 3e). This dele-from this chromosome in the progeny of II-2 (III-2, III-3, III-4).
(b) A second pedigree with a T to C transition in the consensus tion removes bases 287±291 of the 7.9 kb ORF (AGCGG
splice donor (base 2) of intron 4 (AGgtaca to AGgcaca), shown in CCCACT to AGC_ACT), producing a frame shift and
its heterozygous state in the chromatogram. This mutation likely the introduction of a premature stop codon after the
arose in the germline of one of the grandparents in this pedigree.
addition of 8 inappropriate amino acids.(c) A sporadic PH patient with a C to G substitution at the consensus
splice acceptor of intron 3 (3 bases from exon 4, ccacagG to ccagag
G). This mutation likely arose in the germline of one of this patient's
Expression Pattern of FLN1 in Developing Brainparents as the mother does not harbor the base change.
(d) A sporadic patient with a G to A change at the consensus splice Filamin-like immunoreactivity has previously been shown
donor site (base 1) of intron 2 (TCGgt to TCGat). An unrelated control in cultured developing dorsal root ganglion neurons
shows the expected pattern of SSCP bands. (Letourneau and Shattuck, 1989), suggesting a likely
(e) A sporadic patient with a 5 base deletion (AGCGGCCCACT to
role for FLN1 or a related protein as a cell-autonomousAGC_ACT) in exon 2 with a normal control for comparison.
cytoplasmic factor acting in the migrating neuron. North-
ern analysis had previously shown some FLN1 expres-
sion in brain (Maestrini et al., 1993), though recent immu-3a), which converts a CAG (Gln) to a TAG (stop) codon
and truncates the FLN1 protein at amino acid residue nohistochemical analysis in normal adult human brain
showed the expression of FLN1 to be somewhat limited,182 of 2647 (Figure 3a). The mutation demonstrates per-
fect segregation with the PH phenotype in all affected with most expression restricted to various types of blood
Filamin 1 and Neuronal Migration
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Figure 4. Analysis of FLN1 Expression
(a) Commercial Northern blot (Clontech, Palo Alto, CA) containing
poly(A) selected RNA from total mouse embryos from embryonic
day 7, 11, 15, and 17 probed with the FLN1 39 UTR probe. Specificity
of the probe is confirmed by the appearance of a single band at 9.0
kb. Expression is highest at E11, at the onset of neuronal migration.
(b) Northern blot of total RNA from brains of mice from E14 and
E16, P0, and adult (P99 and P286). FLN1 message is most abundant
at E14, and expression remains high through birth but is strongly
downregulated in the adult. The quality of the RNA was checked
by direct visualization following ethidium bromide staining and by
probing the membrane with a G3PD control probe (bottom).
(c) Western analysis of FLN1 expression in human fetal brain (lanes
1 and 2) and postnatal brain. FLN1 appears as two bands that are
commonly seen in other Western blots of FLN1 (Loo et al., 1998) Figure 5. Localization of FLN1 in Cultured Neuronal Cells and in
and appear to represent alternative splice forms. Expression of FLN1 Developing Brain
(compared to a tubulin loading control) decreases substantially dur- (a) Immunofluorescence staining of cultured E15 rat hippocampal
ing postnatal development. neurons after 3 days in culture. Stained neurons show FLN1 immu-
noreactivity throughout their processes, including growth cones.
(b) Similar results were seen using primary mouse cortical cultures
vessels (Zhang et al., 1998). We therefore tested whether and cultured P19 cells differentiated toward neural fates with retinoic
FLN1 might be developmentally regulated in the brain, acid (data not shown).
with high expression during the period of neuronal mi- Scale bars, 30 mm. Controls lacking primary antibody showed com-
plete absence of staining (data not shown).gration and subsequent downregulation. A commercial
(c) Immunohistochemical staining of the intermediate zone of themembrane (Clontech, Palo Alto, CA) containing poly(A)
human cortex at 21±22 weeks gestation, with a hematoxylin counter-selected RNA from total mouse embryos was hybridized
stain. Stained cells show brown immunoreactivity in the perinuclear
with a probe generated from the 39 UTR of the mouse region and in some of the radially oriented cytoplasmic processes
FLN1 message, in order to avoid cross-reactivity with (arrows), as well as blue hematoxylin counterstain. Arrows, 30 mm.
other filamin family members. There was robust expres- (d) Negative control (no primary antibody) shows only cells counter-
stained by the hematoxylin.sion of a single FLN1 message (Figure 4a), demonstra-
ting specificity of the probe. In order to examine FLN1
expression in the developing brain, total RNA from the
brains of E14, E16, P0, and adult mice were subjected as showing lower amounts of expression in glial cells.
Cultured embryonic (E15) rat hippocampal neuronsto Northern analysis using the same probe. Expression
of FLN1 was high at all embryonic time points tested showed robust FLN1 immunoreactivity (Figure 5a) that
was particularly striking in the neurites and growthand was still high at birth, but by adulthood (P99) FLN1
expression was reduced by at least an order of magni- cones. Primary cultures of mouse cortex at E15 also
showed robust staining of neurons and their neuritestude (Figure 4b). These Northern results show that FLN1
is indeed developmentally regulated in brain with high and growth cones (Figure 5b). Cultured P19 cells differ-
entiated toward neural fates using retinoic acid alsoexpression during the period of cortical neuronal migra-
tion (E12±P8 in the mouse) followed by marked down- showed intense FLN1 immunoreactivity throughout the
somata and neuritic processes of neuron-like cells (dataregulation. Western blot analysis of FLN1 in the devel-
oping human brain using a monoclonal antibody raised not shown). Some FLN1 immunoreactivity was also seen
in cultured mouse glial cells and in the flat cells in theto FLN1 (Serotec, Raleigh, NC) showed the presence
of two isoforms (Figure 4c) that have been previously P19 cultures, which are likely to be glial, so that a role
for FLN1 in glia cannot be ruled out.observed and thought to represent alternative splice
forms (Loo et al., 1998). The level of FLN1 protein is Immunohistochemical analysis confirmed that FLN1
is expressed in the developing brain predominantly inagain high in human fetal brain, with lower expression
at postnatal ages (Figure 4c). migrating and postmigratory neurons. Human embry-
onic brain at 21±22 weeks gestation (a period after mostImmunofluorescence analysis of neuronal cultures us-
ing a second monoclonal antibody raised to FLN1 neurogenesis is complete, but while many neurons are
still migrating to the cortex) showed FLN1 expression(Chemicon International, Temecula, CA) demonstrated
robust FLN1 localization in embryonic neurons, as well in bipolar cells of the cortical plate whose morphology
Neuron
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and location were highly suggestive of neuroblasts (data Table 1. Phenotypes in Patients with Documented FLN1
not shown). In the intermediate zone, expression was Mutations
also seen in the cytoplasm of cells that matched the
Patients Number Affected
morphology of radially migrating neurons (Figure 5c),
Heterozygous Femalessuggesting that neurons express FLN1 during radial mi-
gration. Negative controls (lacking primary antibody but Vascular/coagulation
with hematoxylin counterstain) confirmed the specificity Stroke before age 60 2
Stroke before age 20 1of staining (Figure 5d). Strong FLN1 immunoreactivity
was not obvious in glial cells, though lower levels of Cardiac and major vessel
Patent ductus arteriosus 3expression cannot be ruled out.
Bicuspid aortic valve 1
Gastrointestinal
GI motility defects 1Non-CNS Phenotypes in Patients
Extremitieswith FLN1 Mutations
Shortened digits 1In light of the identification of FLN1 mutations in PH, we
Neurologicalreviewed clinical histories and discovered a number of
Congenital strabismus 2additional congenital anomalies common to patients
Small corpus callosum 3with FLN1 mutations (Table 1). For example, 3 of 11
Cerebellar abnormality 4affected females (showing three distinct mutations)
were born with patent ductus arteriosus requiring surgi- Hemizygous Male
cal correction, which has a normal incidence of 1/1500
Vascular/coagulationlive births (Murray, 1997). In addition, 3 of 11 females
Lethal neonatal hemorrhage
with PH suffered strokes at young ages, whereas unaf-
Immunologicfected females in the same pedigrees showed none.
Maturation arrest of bone marrow (erythroid and myeloid)
One affected female and the male carrying the Xq28 Lymphoid depletion of thymus
duplication both had shortened digits, with the male
also showing syndactyly and clinodactyly. Other CNS Male with Large Duplication and PH
malformations included decreased size of the corpus Immunologic
callosum and a cerebellar anomaly described as an en- Immune compromise with recurrent infections
larged cisterna magna or cerebellar cyst, but which may Extremities
represent cerebellar hypoplasia. Other malformations Syndactyly
noted in additional females with PH (in which FLN1 mu- Shortened fingers
Clinodactylytations have not yet been determined), particularly the
high incidence of patent ductus arteriosus, are consis- Neurological
Small corpus callosumtent with the findings in patients with confirmed muta-
Hypoplastic cerebellumtions. Clinical phenotypes in males with FLN1 mutations
are more difficult to elucidate because of the early lethal A compilation of phenotypes in 11 females with confirmed point
mutations in FLN1, one male born alive with a point mutation inphenotype. Interestingly, in the pedigree illustrated in
FLN1, and one male with a large duplication of the FLN1 region.Figure 2a, one male descendant of an affected female
Affected females (total number 5 11 patients, including 8 cases(V-3) who carried the disease-linked haplotype was born
from pedigrees plus three sporadic cases) showed a substantialalive (Figure 2a) but died from severe systemic bleeding
number of patent ductus arteriosus (3 of 11 cases, versus a popula-
and organ failure 3 days later. On postmortem examina- tion incidence of PDA 5 1 per 1500 live births), bicuspid aortic valve
tion, there was severe arrest of myeloid and erythroid (1 of 11 cases, versus a population incidence of 1 per 100 births),
and strokes at early ages (3 of 11). An affected male born carryingdifferentiation in bone marrow and lymphoid depletion
a presumed complete loss-of-function mutation (a CAG to TAG mu-of the thymus.
tation creating a premature termination codon) also showed over-
whelming hemorrhage and arrested myeloid and erythroid bone
marrow development. A male showing a duplication of z2.5 Mbp
X Inactivation Analysis in FLN1 Mutations of DNA, including much of distal Xq28 in addition to FLN1, showed
Given the embryonic lethality of males with FLN1 muta- several features, but some features may have reflected effects of
tions, and the potential requirement for FLN1 in develop- other genes included in the duplication.
ment of some immune cells, we performed X inactivation
studies in female patients with confirmed FLN1 muta-
tions to determine whether FLN1 is required in a cell- strongly preferential expression of the chromosome in-
herited from the mother, carrying the FLN1 mutationautonomous fashion for survival of nucleated peripheral
blood cells (Figure 6). Three patients from the largest (upper band in VI-2 lane). This is reflected by digestion
of the larger allele by HpaII and failure of PCR amplifica-pedigree (Figure 3a) were analyzed for patterns of X
inactivation using the HUMARA marker (Kopp et al., tion of this unmethylated, transcriptionally active allele.
In contrast, the paternally inherited allele (lower band in1997). One patient (III-10) was informative for HUMARA
and showed expression from both the X chromosome VI-2) was preferentially inactivated and hence was not
digested by HpaII and was successfully PCR amplified.carrying the FLN1 mutation and from the normal X chro-
mosome (Figure 6). Another affected female from the Analysis of another mother and daughter pair with a
different mutation (Figure 3b and ªDº and ªMº in Figuresame pedigree (V-2) was not informative for HUMARA;
however, the affected daughter of V-2 (VI-2) showed 6) showed fairly even inactivation of the normal and
Filamin 1 and Neuronal Migration
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the major manifestations are neurological, since males
with hemizygous FLN1 mutations are usually embryonic
lethal. The CNS phenotype has major implications for
the control of neuronal migration, since FLN1 presents
a likely scaffold and target for multiple cytoplasmic sig-
naling proteins that have previously been shown to con-
trol the direction and target selection of migrating neu-
rons. First, we will discuss the implication of FLN1
mutations for previously suspected roles of FLN1 in non-
neuronal cells, and then we will take up the implications
of the previously unsuspected role of FLN1 in neuronal
migration.
Figure 6. X Inactivation Patterns in Several Individuals and Pedi- Properties of FLN1
grees with FLN1 Mutations Are Not Consistently Biased FLN1 was originally identified as a high molecular weight
The figure shows analysis of the HUMARA marker, performed ac- protein isolated from motile blood cells that caused puri-
cording to standard techniques (Kopp et al., 1997). Each pair of fied muscle actin to gel and precipitate (Hartwig and
lanes represents paired experiments in the absence (2) or presence Stossel, 1975), and it was subsequently found to be
(1) of HpaII, a methylation-sensitive enzyme that preferentially
the most abundant and widely distributed member of acleaves nonmethylated sequences within the polymorphic HUMARA
family of large actin-binding proteins (Maestrini et al.,marker. Paternal alles are marked with an asterisk and maternal
alleles are marked with an arrow, except in ª3e,º as this determina- 1993). Immunofluorescence with antibodies to a similar
tion is not possible. The intensity of the two specific bands roughly protein showed localization along actin-rich stress fi-
reflects the balance of X inactivation among peripheral blood nucle- bers, leading to the name filamin (Wang et al., 1975).
ated cells, with the polymorphic allele from the transcriptionally FLN1's most notable feature is its dramatic ability to
active X chromosome being preferentially digested by HpaII (ª1º
induce perpendicular branching of actin filaments at lowlane in each pair of lanes) and hence not amplified. There appears
concentrations (Gorlin et al., 1990). A FLN homolog hasto be no systematic bias in the balance of X inactivation. Affected
patient III-10 from the pedigree shown in Figure 3a is informative also been identified in Dictyostelium discoideum that
for the HUMARA marker but shows no clear skew in X inactivation. regulates actin polymerization (Condeelis et al., 1984),
V-2 is not informative; her daughter is informative, however, and as well as in Drosophila, where filamin is implicated in
preferentially inactivates the paternal allele, suggesting that her X the dorsal signaling pathway through interactions with
inactivation is heavily skewed (as are about 10% of normal females)
the Toll receptor (Edwards et al., 1997). At least threebut actually skewed so that cells expressing the mutant X chromo-
distinct filamin genes are thought to exist in vertebrates,some predominate. Other patients (3b and 3e) showed modest
skewing or balanced X inactivation or were not informative. Since though limited cDNA cloning has hindered careful com-
there is no consistent inactivation of the mutant X chromosome, parisons of primary structure and expression patterns.
FLN1 does not appear to be required in a cell-autonomous fashion FLN1 encodes a 2647 amino acid polypeptide with
for peripheral mononuclear cell survival. three major functional domains (Gorlin et al., 1990). The
N-terminal actin-binding domain (ABD) in FLN1 is struc-
turally similar to the ABDs of dystrophin and a-actinin.abnormal chromosomes in the daughter, while a spo-
radic case (Figure 3e and ª3eº in Figure 6) also showed The bulk of FLN1 forms a semiflexible rod domain com-
posed of 24 repeats, each containing about 96 aminofairly equal expression of both X chromosomes in pe-
ripheral nucleated cells. Analysis of 15 other cases of acids. The rod domain is interrupted twice by short se-
quence inserts of 20±40 residues between repeats 15±16PH in which the specific mutation was not determined
also failed to show preferential X inactivation. Since and 23±24; these regions are postulated to form flexible
hinges and are sites of proteolytic cleavage (Gorlin etX chromosomes carrying the FLN1 mutation are not
preferentially Lyonized in nucleated circulating blood al., 1990). The C terminus contains a truncated repeat
(Figure 7), and this last repeat is the site of dimerizationcells, FLN1 is therefore not required in a cell-autono-
mous fashion for survival of mixed peripheral white of FLN1 (Gorlin et al., 1990) and is the site through which
FLN1 binds to several membrane proteins such as inte-blood cells. However, an essential cell-autonomous role
for FLN1 in a subset of nucleated cells or nonnucleated grin b1 (Loo et al., 1998; Pfaff et al., 1998) and b2 (Sharma
et al., 1995; Glogauer et al., 1998), tissue factor (Ott et al.,cells (e.g., platelets) cannot be excluded, nor can a pos-
sible non-cell-autonomous role for FLN1. 1998), and presenilin 1 (Zhang et al., 1998). In contrast,
another membrane receptor in platelets, glycoprotein
Iba, appears to bind FLN1 through a region that includesDiscussion
repeats 17±19 (Okita et al., 1985; Meyer et al., 1997).
FLN1 is subject to extensive regulation via phosphory-Here, we describe the genetic basis for a new multi-
organ syndrome due to mutations in the human FLN1 lation that alters its subcellular localization and binding
to actin as well as to membrane receptors. For example,gene. We show multiple independent FLN1 mutations
with a similar neurological phenotype and, in two pedi- FLN1 is translocated from the membrane to the cytosol
in endothelial cells in response to bradykinin; this trans-grees, demonstrate the de novo origin of the mutations
as well as linkage between the mutation and the disease location is dependent upon calcium/calmodulin-depen-
dent protein kinase II phosphorylation of the C terminusafter the mutation arises. Strikingly, the major signs of
FLN1 mutations are seen in heterozygous females, and of FLN1 and is inhibited by the cAMP-dependent protein
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that binds to tissue factor (TF), the protease receptor
for coagulation factor VII that initiates the extrinsic coag-
ulation cascade (Ott et al., 1998). TF also has multiple
roles in vascular development, angiogenesis, and tumor
cell metastasis for which the mechanisms are poorly
defined (Bugge et al., 1996). The intracellular domain of
TF binds FLN1, and FLN1 recruitment to TF in response
to extracellular ligands is associated with reorganization
of actin filaments (Ott et al., 1998). Mice with engineered
mutations in TF show virtually 100% embryonic lethality
due to widespread hemorrhage (Bugge et al., 1996). TF/
FLN1 interactions in vascular remodeling may relate to
the elevated incidence of patent ductus arteriosus in
females with FLN1 mutations. The ductus arteriosus,
required for the fetal blood circulation, normally closes
in the hours and days after birth as the postnatal pattern
of blood circulation is established, but in PDA this clo-
sure fails.
FLN1 has a second critical link to hemostasis by acting
in platelets to couple glycoprotein Iba, part of the recep-
tor for von Willebrand's factor (vWF) and thrombin in-
volved in platelet aggregation, to the actin cytoskeleton
(Okita et al., 1985; Meyer et al., 1997). Binding of vWF
to glycoprotein Iba causes FLN1-modulated spreading
of platelets to form a monolayer at the earliest stages
of thrombus formation (Murray, 1997); abnormalities of
this critical function may contribute either to hyperco-
agulability (e.g., strokes suffered at young ages by 3 of
11 affected females) or hemorrhagic disorders. Homozy-
gous mutations in the glycoprotein Iba gene cause a
severe bleeding disorder called the Bernard-Soulier syn-
drome, which is often fatal neonatally (Ware et al., 1990).
Figure 7. Schematic of the Structural Organization of FLN1 as De- The single live-born male carrying a FLN1 mutation who
duced from Several Sources died neonatally of a lethal bleeding disorder thus seems
The figure shows a FLN1 dimer, including the actin-binding domain to represent a phenocopy either of the TF mutant pheno-
(ABD) at the N terminus, the 23 repeats with two hinge regions, one
type or the Bernard-Soulier syndrome.between repeats 15 and 16 and one before repeat 23. Repeat 23 is
Our data provide some evidence for a requirement ofa truncated repeat, which allows dimerization, and the final repeats
FLN1 in immune function, since (1) defects in immunealso represent the region that binds to several integral membrane
proteins including b1 and b2 integrin (Sharma et al., 1995), presenilin development were seen in the male who died neonatally
1 (Zhang et al., 1998), and tissue factor in vascular precursor cells who carried a FLN1 point mutation (Table 1), and (2)
(Ott et al., 1998). Binding sites for several other FLN1-binding pro- defects in immune function are present in a male with
teins such as Trio (Bellanger et al., 1998) and SEK-1 (Marti et al.,
a duplication of Xq28 that included the FLN1 locus.1997) have not yet been identified. The major membrane receptor
Thus, lymphocytes from patients with FLN1 mutationsbound by FLN1 in platelets is glycoprotein Iba, which binds a sepa-
may have functional defects. However, FLN1 does notrate site, including repeats 17±19 (Meyer et al., 1997). The two ABD
heads associate with F actin and recruit actin filaments to regions appear to be required for survival of all nucleated periph-
of active ligand binding to FLN1-bound receptors (Hartwig et al., eral blood cells in a simple, cell-autononous fashion,
1980; Hartwig and Shevlin, 1986; Gorlin et al., 1990; Hartwig, 1992). since X inactivation studies in females with FLN1 muta-
tions failed to show nonrandom patterns of X inactiva-
tion in circulating peripheral blood lymphocytes. In prin-
kinase pathway (Gorlin et al., 1990; Wang et al., 1996). ciple, cell-autonomous requirements for FLN1 function
Phosphorylation by CaM kinase II also regulates the in each component of the peripheral blood (and indeed
actin cross-linking activity of another filamin family in each organ) could be studied by sorting individual cell
member (Ohta and Hartwig, 1995). types from affected females and determining patterns of
X inactivation.
Non-CNS Roles of FLN1 as Revealed FLN1 has been previously implicated as essential for
through Mutations the migration of several cell types, notably melanocytes
FLN1 has several roles in hemostasis and vascular re- (Cunningham et al., 1992), tumor cells, and leukocytes
modeling that may explain the embryonic lethality of (Stendahl et al., 1980). Cultured melanocytes that lack
males with FLN1 mutations, the apparent hypercoagula- FLN1 show defects in pseudopodia formation and ab-
ble state and vascular anomalies of some females with normal surface blebbing, and these defects are cor-
FLN1 mutations, and the neonatal, fatal bleeding disor- rected by transfection of FLN1 cDNA clones (Cunning-
der of a single live-born male with a FLN1 mutation. For ham et al., 1992). Melanocytes that are deficient in FLN1
also show defects in actin dynamics and are excessivelyexample, in vascular cells, FLN1 is the major protein
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sensitive to mechanical deformation (Glogauer et al., be mediated by the known regulation of FLN1-depen-
dent actin cross-linking via cAMP-dependent kinases.1998). Similarly, Dictyostelium discoideum that are defi-
cient in the FLN1 homolog ABP-120 show substantial Abnormalities of the corpus callosum are common in
PH (Table 1) and are likely to reflect defects in axonaldefects in actin cross-linking, pseudopod extension,
cytoskeletal structure, cell motility, chemotaxis, and connections, though an animal model will be needed to
assess this clearly.phagocytosis that are all rescued by transfection of
ABP-120 (Cox et al., 1996). Finally, we note that all of the five FLN1 alleles we have
identified are consistent with complete loss of FLN1
function, representing either mutations at the most
CNS Roles of FLN1 highly conserved residues required for proper splicing,
While the critical role of FLN1 in neuronal migration is nonsense mutations, or frameshift mutations. The typi-
unexpected, FLN1's roles in nonneuronal cells form an cal female PH syndrome appears to correspond to the
obvious precedent for its neuronal role. Controlling the complete loss-of-function state, but milder alleles such
cross-linking of actin filaments, and repetitively forming as amino acid substitutions may ultimately be found to
and breaking focal adhesive contacts, are critical to have milder phenotypes. Perhaps, some milder alleles
the neuronal migration that characterizes the cerebral such as the Xq28 duplication described above will be
cortex. In response to deforming stress applied through nonlethal, albeit neurologically severe, in males. Other
b2 integrin, cultured cells form extensive actin filaments associated findings might include hyper- or hypocoagu-
via recruitment of actin by FLN1 (Glogauer et al., 1998), lable states, vascular malformation, or dysmorphic fea-
suggesting that FLN1 provides the direct link between tures. Thus, FLN1 mutations may ultimately represent a
membrane receptors and the actin cytoskeleton. Given broad phenotypic spectrum with neurological and non-
that FLN1 is expressed in migrating cortical neurons, neurological manifestations.
it is likely that it acts cell-autonomously in migrating
neurons, though a role in radial glial cells cannot be
Experimental Procedures
completely ruled out.
FLN1's central role in binding both receptor and actin SSCP Analysis
make it a prime candidate for being at the center of Exons were amplified by PCR directly from genomic DNA of patients
and controls with Qiagen (Valencia, CA) Taq polymerase accordingthe signal transduction pathway that guides neuronal
to the manufacturer's recommendations. Products were dilutedmigration, with other signaling proteins implicated in
50:50 in SSCP loading buffer (95% formamide, 20 mM NaOH, 20 mMneuronal migration, such as Dab1 and Cdk5/P35, likely
EDTA, 0.05% bromophenol blue, 0.05% xylene cyanol), incubated at
to play regulatory roles. For example, Dab1 is an adapter 958C for 5 min, and flash cooled on ice. Products were loaded
protein with some homology to Shc and Numb, which onto nondenaturing, 0.53 MDE acrylamide gels (FMC Bioproducts,
both bind directly to membrane receptors (Howell et al., Rockland, ME) in 0.63 TBE and run at a constant 8 W for 16 hr at
room temperature. Gels were stained with the Promega (Madison,1997). Since Dab1 appears to transduce a ªstopº signal
WI) Silver Staining Kit according to the manufacturer's instructions.from the secreted ligand, Reelin (Rice et al., 1998), a
simple model would have Dab1 blocking radial migration
DNA Sequencingby disrupting FLN1 binding to a membrane receptor.
Normal and aberrantly migrating bands from the stained SSCP gelsThe protein hypothetically bound by Dab1 and FLN1
were covered with 1 ml polyacrylamide gel elution buffer (0.5 Mwould then be a candidate receptor for Reelin. Cdk5/
ammonium acetate, 10 mM magnesium acetate, 1 mM EDTA [pH
P35 may also regulate the interaction of FLN1 with re- 8.0], 0.1% SDS), excised with a clean razor blade, macerated in an
ceptor via phosphorylation of the receptor-binding C additional 25 ml elution buffer, and incubated at 378C for .3 hr.
terminus, since the CANSEARCH program (Songyang Supernatant (0.5 ml) was used as template for PCR reactions to
reamplify products from excised bands. These products, along withet al., 1995; Zhou and Cantley, 1995; Nishikawa et al.,
the original heterozygous products run on the SSCP gels, were gel1997) identifies many consensus phosphorylation sites
purified (Geneclean Kit, Bio 101, Vista, CA) and sequenced with thefor Cdk5/P35 (residues 2640, 2414, 1630, 2599, and
Big Dye Cycle Sequencing Kit (Applied Biosystems, Foster City, CA)
1148, all .97% probability) at the C terminus of FLN1. according to the manufacturer's protocol using the same primers
Hence, loss of Cdk5/P35 (Ohshima et al., 1996; Chae et used for the initial PCR reactions. Sequencing products were run
al., 1997) function would resemble loss of Dab1 function. on an ABI 377 automated sequencer and analyzed using the
Sequencher program (GeneCodes, Ann Arbor, MI). All mutationsFLN1's role in the CNS also likely involves migration
were verified by reamplifying products from genomic DNA and re-of other neuronal types and perhaps axon outgrowth.
peating the SSCP analysis and sequencing.The cerebellum is often subtly abnormal in PH, and addi-
tional CNS regions may be abnormal in hemizygous
Northern Analysismales. Moreover, neuronal migration and axon out-
Whole brains were extracted from E14, E16, P0, and adult mice,growth bear considerable morphological similarities,
and RNA was extracted in TriReagent (Sigma, St. Louis, MO) ac-
and many of the genes involved in one are also involved cording to the manufacturer's instructions. RNA (10 mg) from each
in the other. Therefore, FLN1 would be an excellent sample was run on a denaturing 1% agarose gel for 5 hr at 7.5
V/cm. The gel was stained with ethidium bromide and photographedcandidate to control actin gelation and filopodia forma-
on a UV transilluminator. No significant degradation was observedtion in growth cone extension. For example, cAMP regu-
for any sample, and clear 18 and 28S ribosomal bands were visiblelates axon turning (Ming et al., 1997) and has long been
in each lane at roughly equal intensities. The RNA was transferredknown to control chemotaxis in Dictylostelium dis-
overnight by capillary action in 203 SSC to a positively charged
coideum via regulation of the FLN1 homolog ABP-120 nylon membrane (Hybond N1, Amersham, Piscataway, NJ) and
through a cAMP-dependent kinase (Cox et al., 1996). fixed by UV cross-linking (120,000 J/cm2) and baking at 708C for 1
hr. The 39 FLN1 probe was labeled with [32P]dCTP by random primingChemotactic-like cAMP effects on axons could logically
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